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Abstract  
Introduction: Chronic myelogenous leukemia (CML), the most common sub-type of leukemia, usually 
presents with anorexia, fatigue, weight loss, splenomegaly, infection, and bleeding diasthesis. Cranial nerve 
palsy is a rare occurrence with myelo-proliferative disorder. Though prior literatures reported cranial 
neuropathies with different myelo-proliferative disorders, commonly acute leukemias and lymphomas, this is 
the first case of CML presenting with oculomotor nerve palsy. 
Presentation of case: We report a 55-year old African American male presented in emergency department 
with features of third cranial nerve palsy, including unilateral ptosis, diplopia, and downward-outward 
deviation of eyeball without involvement of pupil. Clinical suspicion of CML, based on preliminary routine 
laboratory investigation, was confirmed by bone marrow biopsy and genetic testing of marrow aspirate. 
Patient was treated with Imatinib and regularly followed up with complete blood count. 
Conclusion: CML may present with lone cranial nerve palsy as the first clinical finding. Hence, we 
emphasize to consider leukemia as one of the possible differential diagnoses in suspected patients presenting 
with isolated oculomotor palsy, if no other cause is evident. 
 
 
American Journal of Cancer Case Reports 
http://ivyunion.org/index.php/ajccr/ 
 
Ivy Union Publishing | http: //www.ivyunion.org May 31, 2016 | Volume 4, Issue 1 
Adhikari BK A et al. American Journal of Cancer Case Reports 2016, 4:51-58
6
Page 2 of 8 
Introduction 
Chronic myelogenous leukemia (CML) is a myelo-proliferative neoplasm caused by the translocation 
between break point cluster region (BCR) gene on chromosome 22 and Abelson 1 (ABL1) on 
chromosome 9 leading to BCR-ABL1 gene fusion (Philadelphia chromosome), and producing 
constitutive activation of ABL1, a gene coding for tyrosine kinase [1,2]. Being the common type, 
CML constitutes 10-15% of all leukemias [3]. The annual incidence of CML is approximately 1-1.5 in 
100,000 population worldwide, with an estimated 6,650 new cases in the year 2015 [4,5]. Moreover, 
the prevalence is increasing due to increased survival with the advancement of BCR-ABL tyrosine 
kinase inhibitors [6]. 
Of the chronic, accelerated, and blast crisis phases of CML, most of the cases (85-95%) are 
diagnosed in chronic phase [3,7], and up to 50% of patients are asymptomatic at the time of diagnosis 
[8]. Central nervous system (CNS) involvement of chronic leukemia, cranial nerve in particular, is 
very rare. An autopsy study conducted on 100 subjects who died of active leukemia suggested that 
CNS involvement is more common in acute than chronic leukemia. In the study, 81% of acute 
lymphoblastic leukemia (ALL) and 46 % of acute myelogenous leukemia (AML) cases revealed CNS 
infiltration in autopsy, while eight of sixteen cases with chronic lymphocytic leukemia (CLL) and a 
single case with CML evidenced CNS involvement [9].  
We performed a meticulous literature search in various databases, such as Pubmed/Medline, 
Google Scholar, and the references from review articles, to identify the cases that have reported 
oculomotor nerve (CN III) palsies associated with myelo-proliferative disorders (Table 1). However, to 
the best of our knowledge, this is the first case that describes CN III palsy as the sole presentation of 
CML.  
Case Presentation 
A 55-year old African American male presented to the emergency department with diplopia and 
drooping of left eyelid for nine days. Patient reported sudden onset of double vision, and downward 
and outward deviation of his left eyeball which was followed by left eyelid drooping after three days. 
He mentioned that the diplopia resolved on persistently closing the affected eye. Patient denied any 
history of weight loss, fever, anorexia, fatigue, chest pain, limb or facial weakness, and photophobia. 
There was no any discharge, pain, swelling, or redness of his eyes. The patient had past medical 
history of diabetes mellitus (DM), and chronic back pain. Prior to admission, his medications were 
fentanyl and oxycodone for his back pain; glipizide, insulin glargine, insulin lispro protamine, and 
sitagliptin-metformin for his DM. He had undergone right knee joint replacement surgery in 2004. 
Patient had been chronic smoker (7-8 cigarettes per day) for the last 20 years, but denied the use of 
alcohol or illicit drugs.  
On examination, patient was well oriented to time, place and person. He was morbidly obese with 
BMI of 51.9. Physical examination showed temperature of 37.2 C (98.9 F), pulse 80 per min, blood 
pressure 132/94 mmHg, and respiratory rate 14 breaths per minute. Complete ptosis of the left eye was 
evident with outward and downward deviation of eyeball on lid retraction. When the patient was asked 
to open the affected eye, the contra-lateral eye deviated laterally. Funduscopic examination revealed 
early signs of diabetic retinopathy in both eyes with more severe retinopathy in the unaffected right 
eye. Notably, pupil in the affected eye was not reactive to light. The features were suggestive of CN III 
palsy with pupillary involvement. Neither lymph node nor liver/spleen was palpable. Physical 
examination of the heart and lungs were unremarkable. The abdomen was soft, non-tender and bowel 
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sounds were appreciated. The neurological exam was otherwise unremarkable. 
Baseline laboratory data revealed blood glucose of 285 mg/dL, and a hemoglobin A1c of 11.4%. 
The complete blood count was significant for a white blood cell count of 35.7 K/uL, with red blood 
cell MCV of 80.1 fl. The hemoglobin was 11.9 mg/dL, hematocrit was 38.7 %, and platelet count was 
228,000/UL. Complete blood count showed a distribution of 74.8% granulocytes, 15.1 % lymphocytes, 
7.2% monocytes, 3.5% basophils, and 1.5% eosinophils. The absolute numbers of all blood cells were 
increased except for eosinophil. The liver function test was unremarkable except for alkaline 
phosphatase of 115 units/L and lactate dehydrogenase of 545 units/L. 
Peripheral blood smear showed a left shift with 20% myelocytes, basophilia, neutrophilia, and no 
blast cells. Head CT showed no tumors or aneurysms impeding on CN III. HIV testing, blood culture, 
urine culture, and CSF cultures were all negative. On admission, laboratory results revealed an 
unexceptional complete metabolic panel with sodium of 139 mmol/L, potassium of 4.2 mmol/L, 
chloride of 102 mmol/L, bicarbonate of 25 mmol/L, blood urea nitrogen of 22 mg/dL, and creatinine 
of 1.1 mg/dL. The remaining liver function tests showed a total bilirubin of 0.3 mg/dL, alanine 
aminotransferase of 27 units/L, and aspartate aminotransferase of 31 units/L, while total protein and 
albumin were 6.8 g/dL and 2.9 g/dL respectively.  
The patient’s initial differential diagnoses were leukemoid reaction secondary to infection and 
CML. As a precaution, the patient was started on doxycycline to treat for possible Lyme disease. 
Antibiotics were discontinued after ruling out Lyme disease by a negative Lyme panel. The bone 
marrow yielded no abnormal findings on flow cytometry. However, bone marrow biopsy revealed 
granulocytic hyperplasia. A FISH for BCR-ABL1 translocation of the bone marrow aspirate was 
positive. The patient was immediately treated with Imatinib 400mg/day. The patient was advised for 
outpatient follow-up where the response to treatment was monitored with complete blood count.  
Discussion 
We describe the unique presentation of left oculomotor palsy in a patient who was later diagnosed with 
CML. Prior to this report, two different cases were reported on CML presenting with CN palsy [11,12]. 
One study reported a case of 53-year old male with signs of hyperemia and slight edema in 
funduscopy (CN II involvement), without any presenting symptoms [11], while the other reported 61 
year-old male diagnosed with CML presented with unilateral diplopia and lateral rectus muscle palsy 
(CN VI). Furthermore, there were 16 different articles with 17 patients of CN III palsy associated with 
different myelo-proliferative disorders, of which majority [7,13-19] was associated with different 
types of Non-Hodgkin's lymphoma (n=9), followed by ALL (n=3) [20-22]. Remaining five cases were 
associated with each of AML [23], Hodgkin's lymphoma [24], infectious mononucleosis [25], 
leukemic meningitis [26], post-transplant lympho-proliferative disorders [27] (Table 1). However, 
none of the CML case was associated with CN III palsy suggesting latter as a very rare presentation of 
CML. 
Due to the patient’s body habitus, an MRI could not be performed. As an alternative to MRI, CT 
angiography of the head with contrast and CSF exam was performed on our patient; both showed no 
abnormalities suggesting that normal findings in neuroimaging and CSF do not rule out the possibility 
of CN involvement in leukemic patients. This finding is replicated in another study [20], which 
showed no abnormalities in either brain MRIs with or without intravenous gadolinium, or magnetic 
resonance venography in a patient with T-cell acute lymphoblastic leukemia and right oculomotor 
palsy. Additionally, CSF studies in this patient demonstrated normal results.  
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The patient’s history of uncontrolled diabetes puts him at great risk for diabetic mono-neuropathy 
which was the first and the most important differential to be considered in our patient. 
Ophthalmoplegia is associated with 0.4% of diabetic patients and isolated CN III palsy accounted for 
59.3% of such cases [28]. The clinical presentation of oculomotor nerve palsy in a diabetic patient is 
acute-onset diplopia and ptosis without involvement of pupil. Sparing of pupil is an important 
distinction between diabetic neuropathy and other ophthalmoplegias such as aneurysms, tumors, 
masses or infiltrative processes [29]. Hence, absence of pupillary reaction to light (pupillary 
involvement), and abnormality in the routine white blood cells count urged us to rule out diabetes and 
consider leukemia as the most likely diagnosis which was later confirmed with further investigation. 
Diabetic cranial nerve neuropathy affects somatic fibers and not parasympathetic fibers. While isolated 
III cranial nerve palsy is rare in diabetic patients, it cannot be excluded from our differentials, which 
includes hematologic infiltration, infectious etiologies, and diabetic mono-neuropathies. The 
pathogenesis for involvement of the left oculomotor nerve in CML is not clear. However, we believe 
that infiltrative myelogenous cells may induce inflammation or compression of the nerve fibers 
leading to the presenting symptoms. 
Conclusion 
To the best of our knowledge, this is the first case report of CN III palsy presenting as the only clinical 
feature of CML. However, there have been isolated cases of oculomotor palsy due to other 
hematological neoplasia. Based on our report, we emphasize that clinician should consider the 
possibility of CML in an unexplained, suspected cases of cranial nerve palsy.  
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Table 1 Summary of case/case-series reports of cranial nerve palsies associated with myelo-proliferative disorders. 






Clinical Features and/or findings Conclusion 
Bhatt VR et al. 2012 28/F III ALL Sudden onset R CN III palsy, normal neuro-radiography and 
CSF studies 
T-ALL involving CN III despite normal 
neuro-radiography and initial CSF studies. 
Oz O et al. 2011 48/M III ALL L CN III palsy, ptosis, diplopia, lymphoblastic infiltration of 
both cavernous sinuses on MRI 
First case of ALL presenting with CN III palsy 
 
Al-Mujaini AS et al.  2009 25/M III AML U/L CN III palsy AML presenting as acute CN III palsy 
Tabata M et al. 1998 53/M III AML Diplopia, R blepharoptosis, MRI: B/L enlargement of CN III; 
partial remission with intrathecal MTX & CA 
MRI can be helpful in early diagnosis of leukemia. 
Kiratli H et al.  10/M III BAL  R Superior rectus palsy, proptosis Leukemic infiltration of extraocular muscles in BAL. 
Levy J et al. 2006 34/M III BL 
(NHL) 
Headache, L eye pain, diplopia, complete ptosis for several 
hours, pupillary involvement 
BL should be considered in any patient presenting 
with diplopia or ophthalmoparesis. 
Park YM et al. 
 
2007 53/F III DLBCL 
(NHL) 
Headache, diplopia, ptosis, mydriasis, outward positioning of 
eyeball,CD20 positive, CD3 negative 
Complete CN III palsy as a presenting feature of 
Large BCL 
Sato H et al. 
2011 
 
71/M III DLBCL 
(NHL) 
Diplopia, mild ptosis, complete L CN palsy, no pupillary 
involvement 
Isolated CN III palsy is associated with Large BCL 
89/F III DLBCL 
(NHL) 
Diplopia, L ptosis, no pupil or visual acuity affected 
Tsai CH et al. 2013 51/F III DLBCL 
(NHL) 
Dropped eyelid, blurred vision, anisocoria, complete CN III 
paresis 
CN III palsy can occur in patient with DLBCL 
Meireles J et al. 2014 69/F III HL Ptosis, diplopia HL presenting as isolated CN III palsy. 
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Clinical Features and/or findings Conclusion 
Erben Y et al. 2007 19/M III IM R headache, sub-acute diplopia IM presenting as isolated CN III neuritis 
Bhatti MT et al. 2005 45/M III DLBCL 
(NHL) 
Isolated CN III palsy, involvement of pupil, HIV positive CNS lymphoma presenting as isolated CN III palsy. 
Celebisoy N et al. 2008 56/M III LM R diplopia and ptosis, intermittent frontal headache, BM 
findings consistent with myelofibrosis. 
CNS leukemia presenting as isolated CN III palsy 
Chen CS et al. 2008 58/M III NKTL 
(NHL) 
Proptosis of R eye, complete R CN III palsy CN III palsy can be caused by intracranial extension of 
a sino-orbital NKTL 
Manabe Y et al. 2000 - III NHL Eyelid lifting, vertical gaze palsy; normal Lateral gaze, no 
involvement of pupil 
Partial CN III palsy could occur as the first sign of 
NHL 
Metellus P et al. 2002 64/M III NHL 
CN III palsy, diplopia, Headache, mass in sphenoidal sinus on 
MRI 
CN III involvement with NHL 
Kraus TS et al. 2014 8/M III PTLD Heart transplant patient with CN III palsy, features of 
angioblastic T-Cell lymphoma 
CN III palsy associated with monomorphic T cell 
PTLD in heart-transplant patient. 
Note: ALL=Acute Lymphoblastic Leukemia; ALL=Acute Myeloblastic Leukemia; BAL=Biphenotypic Acute Leukemia; BL=Burkitt's Lymphoma; B/L=Bilateral; BM=Bone Marrow; 
CD=Cluster Differentiation; CN=Cranial Nerve; CNS=Central Nervous System; CSF=Cerebrospinal Fluid; CA=Cytosine Arabinoside; DLBCL=Diffuse Large B-Cell Lymphoma; 
F=Female; HL=Hodgkin's Lymphoma; L=Left; LM=Leukemic Meningitis; IM=Infectious Mononucleosis; M=Male; MD=Myeloproliferative Disorder; MRI=Magnetic Resonance 
Imaging; MTX=Methotrexate; NHL= Non-Hodgkin's Lymphoma; NKTL=Natural Killer/T-Cell Lymphoma; PTLD=Post-transplant Lympho-proliferative Disorder; R=Right; L=Left; 
U/L=Unilateral. 
 
 
